LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 93.92 | 21.74 | 4095 | 6070 | 0.6746 | 0.9054 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 93.92 | 21.74 | 22 | 6070 | 0.0036 | 0.0015 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 93.92 | 21.74 | 2720 | 6070 | 0.4481 | 0.8119 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 2.24 | 21.74 | 395 | 183 | 2.1518 | 1.5654 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 2.24 | 21.74 | 539 | 183 | 2.9362 | 1.8380 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 4.24 | 21.74 | 716 | 317 | 2.2531 | 1.4671 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 4.24 | 21.74 | 743 | 317 | 2.3381 | 1.4909 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 6.21 | 21.74 | 881 | 392 | 2.2474 | 1.4284 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 6.21 | 21.74 | 823 | 392 | 2.0995 | 1.3891 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 8.19 | 21.74 | 961 | 439 | 2.1848 | 1.3947 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 8.19 | 21.74 | 899 | 439 | 2.0438 | 1.3582 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 10.16 | 21.74 | 2 | 463 | 0.0043 | -0.4175 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 10.16 | 21.74 | 986 | 463 | 2.1266 | 1.3728 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 10.16 | 21.74 | 1 | 463 | 0.0022 | -0.5022 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 10.16 | 21.74 | 911 | 463 | 1.9649 | 1.3306 | MN20160310_N01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 12.13 | 21.74 | 1 | 496 | 0.0020 | -0.4945 | MN20160310_N01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 12.13 | 21.74 | 1014 | 496 | 2.0429 | 1.3430 | MN20160310_N01 | H17 |